Gsk (GSK) EV to CFO (2026)

Gsk (GSK) has 18 years of EV to CFO data on file, last reported at 7.37 in Q3 2026.

• For the quarter ending Q3 2026, EV to CFO changed N/A year-over-year to 7.37; the trailing twelve-month figure through Sep 2026 stood at 7.37 (changed N/A YoY), and the FY2025 full-year result was 9.77, up 21.22% from the prior year.
• EV to CFO was 7.37 for Q3 2026 at Gsk, down from 8.69 in the prior quarter.
• In the past five years, EV to CFO ranged from a high of 12.18 in Q4 2023 to a low of 5.31 in Q3 2022.
• A 5-year average of 8.98 and a median of 8.69 in 2026 frame the typical range for EV to CFO.
• Across the five-year window, EV to CFO soared 73.07% in 2023 and slumped 34.12% in 2024, its largest moves.
• Gsk's EV to CFO stood at 7.04 in 2022, then jumped by 73.07% to 12.18 in 2023, then slumped by 34.12% to 8.03 in 2024, then rose by 8.52% to 8.71 in 2025, then slipped by 15.34% to 7.37 in 2026.
• Per Business Quant data, the three most recent EV to CFO figures were 7.37 in Q3 2026, 8.69 in Q2 2026, and 9.8 in Q1 2026.